🇺🇸 FDA
Patent

US 6132962

Retroviral vectors comprising an anti-hiv or other nucleic acid

expired A61KA61K38/00A61K48/00

Quick answer

US patent 6132962 (Retroviral vectors comprising an anti-hiv or other nucleic acid) held by The Regents of the University of California expires Mon Oct 12 2020 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Oct 17 2000 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Oct 12 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
23
CPC classes
A61K, A61K38/00, A61K48/00, A61P, A61P31/12